Goldman Sachs predicts FDA will approve coronavirus vaccine this year

Goldman Sachs expects the Food and Drug Administration to approve at least one coronavirus vaccine this year.

"While highly uncertain, our baseline expectation is that a large number of vaccines eventually gain approval with at least one FDA approval this year," Daan Struyven, a senior economist at Goldman, told investors in a report on Monday. .

regulatory approval of an initial vaccine would allow them to get vaccinated by October.

"For context, it took hepatitis B — the disease with the largest number of attempts — decades to reach the number of developments COVID-19 has sparked in a few quarters," Struyven said.

Although Goldman said drugmakers are moving quickly to develop possible vaccines, the Wall Street firm also sought to temper expectations about their efficacy in combating the virus. .

"An early [FDA} approval does not imply full effectiveness or long-run protection," Struyven said

© 2020 CBS Interactive Inc.

Copyright © 2020 CBS Interactive Inc